Radboud University Medical Center

🇳🇱Netherlands

Country: 🇳🇱Netherlands

Ownership: Private

Established: 1951-01-01

Employees: -

Market Cap: -

Website: http://www.radboudumc.nl

Clinical Trials

Non-specific Effects of Vaccination on Mortality and Morbidity

Conditions: Anemia
Malaria,Falciparum
Vaccine Reaction
Salmonella Bacteraemia

Interventions: Other: Venipuncture

First Posted Date: 2017-06-05

Last Posted Date: 2018-09-04

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 1005

Registration Number: NCT03176719

Locations: 🇧🇫
Clinical Research Unit of Nanoro, Nanoro, Boulkiemedé, Burkina Faso

Lengthening Adalimumab Dosing Interval in Quiescent Crohn's Disease Patients

Phase 4

Conditions: Crohn Disease in Remission
Crohn Disease

Interventions: Other: Lengthening adalimumab dosing interval

First Posted Date: 2017-06-01

Last Posted Date: 2022-10-14

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 174

Registration Number: NCT03172377

Locations: 🇳🇱
Radboudumc University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands
🇳🇱
Jeroen Bosch Ziekenhuis, 's Hertogenbosch, Noord-Brabant, Netherlands
🇳🇱
Amphia Ziekenhuis, Breda, Noord-Brabant, Netherlands

and more 19 locations

The Role of Stem Cells on Immune Cells in the Development of Cardiovascular Diseases

Completed

Conditions: Atherosclerosis
Cardiovascular Diseases

First Posted Date: 2017-06-01

Last Posted Date: 2019-04-01

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 27

Registration Number: NCT03172507

Locations: 🇳🇱
Department of cardiology, CWZ, Nijmegen, Gelderland, Netherlands
🇳🇱
Department of cardiology, Radboudumc, Nijmegen, Gelderland, Netherlands

S. Aureus Decolonization in HPN Patients.

Not Applicable

Terminated

Conditions: Motility Disorder
Staphylococcus Aureus

Interventions: Drug: Doxycycline
Drug: Trimethoprim
Drug: Sulfamethoxazole/trimethoprim
Drug: Clindamycin
Drug: Clarithromycin
Drug: Ciprofloxacin
Drug: Fusidic Acid
Drug: Rifampin
Drug: Chlorhexidine
Drug: Mupirocin
Drug: Betadine

First Posted Date: 2017-06-01

Last Posted Date: 2022-05-31

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 63

Registration Number: NCT03173053

Locations: 🇩🇰
Rigshospitalet, Copenhagen, Denmark
🇩🇰
Aalborg Universitetshospital, Aalborg, Denmark
🇳🇱
Radboud UMC, Nijmegen, Gelderland, Netherlands

and more 1 locations

Validation of CardioQ Versus PiCCO in Children

Not Applicable

Recruiting

Conditions: Cardiac Output

Interventions: Device: CardioQ

First Posted Date: 2017-06-01

Last Posted Date: 2023-04-18

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 17

Registration Number: NCT03172689

Locations: 🇳🇱
Radboud Univeristy Medical Center, Nijmegen, Gelderland, Netherlands

Disturbing Factors in the Operating Room

Completed

Conditions: Stress
Disturbing Factors

Interventions: Device: HealthPatch

First Posted Date: 2017-05-23

Last Posted Date: 2017-05-31

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 45

Registration Number: NCT03163537

Immunomodulation of EA-230 Following On-pump Coronary Artery Bypass Grafting (CABG)

Phase 2

Conditions: Systemic Inflammatory Response Syndrome
Coronary Artery Bypass Grafting

Interventions: Drug: EA-230
Other: Placebo (NaCl)

First Posted Date: 2017-05-09

Last Posted Date: 2018-06-26

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 180

Registration Number: NCT03145220

Locations: 🇳🇱
Intensive care, research unit, Radboud University Medical Centre, Nijmegen, Gelderland, Netherlands

Safety and Protective Efficacy of Pb(PfCS@UIS4)

Phase 1

Completed

Conditions: Malaria,Falciparum
Plasmodium Falciparum
Plasmodium Berghei
Controlled Human Malaria Infection (CHMI)

Interventions: Biological: Pb(PfCS@UIS4)-infected mosquitoes
Other: Challenge infection P. falciparum

First Posted Date: 2017-05-03

Last Posted Date: 2022-03-04

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 24

Registration Number: NCT03138096

Locations: 🇳🇱
Havenziekenhuis, Rotterdam, Netherlands
🇳🇱
Radboud university medical center, Nijmegen, Gelderland, Netherlands

Micafungin Pharmacokinetics in Obese Patients

Phase 4

Completed

Conditions: Morbid Obesity

Interventions: Drug: Micafungin

First Posted Date: 2017-04-06

Last Posted Date: 2020-10-19

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 24

Registration Number: NCT03102658

Locations: 🇳🇱
St Antoniusziekenhuis, Nieuwegein, Netherlands
🇳🇱
Radboudumc CRCN, Nijmegen, Netherlands

'Fibrosis in the Lost Hepatitis C Population - Track, Trace and Treat'

Completed

Conditions: Chronic Hepatitis c

First Posted Date: 2017-03-23

Last Posted Date: 2020-02-10

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 106

Registration Number: NCT03088917

Locations: 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy